208 related articles for article (PubMed ID: 16402907)
21. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
[TBL] [Abstract][Full Text] [Related]
22. Potential Roles of Protease Inhibitors in Cancer Progression.
Yang P; Li ZY; Li HQ
Asian Pac J Cancer Prev; 2015; 16(18):8047-52. PubMed ID: 26745037
[TBL] [Abstract][Full Text] [Related]
23. Activity-based probes for the study of proteases: recent advances and developments.
Serim S; Haedke U; Verhelst SH
ChemMedChem; 2012 Jul; 7(7):1146-59. PubMed ID: 22431376
[TBL] [Abstract][Full Text] [Related]
24. Extracellular proteases in atherosclerosis and restenosis.
Garcia-Touchard A; Henry TD; Sangiorgi G; Spagnoli LG; Mauriello A; Conover C; Schwartz RS
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1119-27. PubMed ID: 15802622
[TBL] [Abstract][Full Text] [Related]
25. Proteases.
Barrett AJ
Curr Protoc Protein Sci; 2001 May; Chapter 21():Unit 21.1. PubMed ID: 18429162
[TBL] [Abstract][Full Text] [Related]
26. Action of antiproteases on pancreatic cancer cells.
Uchima Y; Sawada T; Hirakawa K
JOP; 2007 Jul; 8(4 Suppl):479-87. PubMed ID: 17625304
[TBL] [Abstract][Full Text] [Related]
27. Looking at the proteases from a simple perspective.
Castro HC; Abreu PA; Geraldo RB; Martins RC; dos Santos R; Loureiro NI; Cabral LM; Rodrigues CR
J Mol Recognit; 2011; 24(2):165-81. PubMed ID: 21360607
[TBL] [Abstract][Full Text] [Related]
28. A protease activity-depleted environment for heterologous proteins migrating towards the leaf cell apoplast.
Goulet C; Khalf M; Sainsbury F; D'Aoust MA; Michaud D
Plant Biotechnol J; 2012 Jan; 10(1):83-94. PubMed ID: 21895943
[TBL] [Abstract][Full Text] [Related]
29. Expression and activation of proteases in co-cultures.
Paduch R; Kandefer-Szerszeń M
Exp Toxicol Pathol; 2011 Jan; 63(1-2):79-87. PubMed ID: 19836935
[TBL] [Abstract][Full Text] [Related]
30. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
Jodele S; Blavier L; Yoon JM; DeClerck YA
Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
[TBL] [Abstract][Full Text] [Related]
31. [Proteases by reactive stromal cells in cancer: an attractive therapeutic target].
Têtu B; Trudel D; Wang CS
Bull Cancer; 2006 Sep; 93(9):944-8. PubMed ID: 16980237
[TBL] [Abstract][Full Text] [Related]
32. Local proteolytic activity in tumor cell invasion and metastasis.
Ludwig T
Bioessays; 2005 Nov; 27(11):1181-91. PubMed ID: 16237672
[TBL] [Abstract][Full Text] [Related]
33. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
34. Use of fluorescent imaging to investigate pathological protease activity.
Blum G
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):708-16. PubMed ID: 18729022
[TBL] [Abstract][Full Text] [Related]
35. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter.
Tung CH; Mahmood U; Bredow S; Weissleder R
Cancer Res; 2000 Sep; 60(17):4953-8. PubMed ID: 10987312
[TBL] [Abstract][Full Text] [Related]
36. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.
Mueller MM; Fusenig NE
Differentiation; 2002 Dec; 70(9-10):486-97. PubMed ID: 12492491
[TBL] [Abstract][Full Text] [Related]
37. Nanoscale imaging and quantification of local proteolytic activity.
Kusick S; Bertram H; Oberleithner H; Ludwig T
J Cell Physiol; 2005 Sep; 204(3):767-74. PubMed ID: 15744770
[TBL] [Abstract][Full Text] [Related]
38. Global Protease Activity Profiling Identifies HER2-Driven Proteolysis in Breast Cancer.
Salcedo EC; Winter MB; Khuri N; Knudsen GM; Sali A; Craik CS
ACS Chem Biol; 2021 Apr; 16(4):712-723. PubMed ID: 33765766
[TBL] [Abstract][Full Text] [Related]
39. Functional protease profiling for diagnosis of malignant disease.
Findeisen P; Neumaier M
Proteomics Clin Appl; 2012 Jan; 6(1-2):60-78. PubMed ID: 22213637
[TBL] [Abstract][Full Text] [Related]
40. The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy.
Vizovisek M; Ristanovic D; Menghini S; Christiansen MG; Schuerle S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
